百洋医药:子公司拟约1100万美元认购Zap Medical优先股

智通财经
Yesterday
【百洋医药:子公司拟约1100万美元认购Zap Medical优先股】百洋医药公告,全资子公司百洋健康产业国际商贸有限公司拟行使认股权证权利,按照行权价格每股0.723美元认购Zap Medical发行的E-1系列优先股1521.44万股,投资总金额约为1100万美元。本次投资完成后,公司间接合计持有Zap Medical 20.86%的股权。本次交易不会导致公司合并报表范围变更。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10